stockrowAptarGroup, Inc.
ATR Healthcare Medical Instruments & Supplies
AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.
- Revenue
- +6.03%
- EPS
- −73.9%
- Free cash flow
- −16.9%
- Total debt
- +14.6%
Quarter to September 2026, against a year earlier
Follow ATR
Alert me
AptarGroup, Inc. (ATR) EBITDA
AptarGroup, Inc.'s EBITDA for fiscal 2025 was $788.4M, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $783.0M. Over the past ten years it has ranged from $458.0M (fiscal 2018) to $788.4M (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 5 consecutive fiscal years. AptarGroup, Inc. ranks 13th of 47 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $788.4M | 3.70% |
| FY2024 | $760.3M | 16.50% |
| FY2023 | $652.6M | 6.47% |
| FY2022 | $613.0M | 5.29% |
| FY2021 | $582.2M | 4.00% |
| FY2020 | $559.8M | (1.14%) |
| FY2019 | $566.2M | 23.63% |
| FY2018 | $458.0M | (3.90%) |
| FY2017 | $476.6M | 1.73% |
| FY2016 | $468.5M | 1.18% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $210.6M | 2.03% |
| Jun 2026 | $206.4M | 12.63% |
| Mar 2026 | $183.2M | 0.20% |
| Dec 2025 | $182.9M | (13.81%) |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| SOLV Solventum Corporation compare | $2.6B |
| BAX Baxter International Inc. compare | $1.5B |
| COO The Cooper Companies, Inc. compare | $928.2M |
| AVTR Avantor, Inc. compare | $913.6M |
| ALGN Align Technology, Inc. compare | $802.0M |
| BLCO Bausch + Lomb Corporation compare | $801.0M |
| ATR AptarGroup, Inc. | $783.0M |
| TFX Teleflex Incorporated compare | $256.2M |
| RGEN Repligen Corporation compare | $155.0M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on ATR
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement